Quanterix Corp (QTRX):企業の製品パイプライン分析2018

◆英語タイトル:Quanterix Corp (QTRX) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C2870
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Quanterix Corp (Quanterix) is a medical equipment provider that offers proteins measurement solutions. The company’s products include biomarker detection system, assay kits, single molecule detector and analyzers. It provides clinical sample and outsourced testing, custom assay development, assay feasibility testing and prototype development, assay optimization and assay validation through its innovative accelerator lab. Quanterix’s technologies are used in life sciences research, oncology, neurology, inflammatory disease and infectious disease areas. The company offers certificates for analysis that are conducted using its products. It partners with sports and healthcare sectors to detect symptoms and signs of injuries. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Quanterix Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Quanterix Corp Company Overview 5
Quanterix Corp Company Snapshot 5
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Quanterix Corp – Pipeline Analysis Overview 8
Quanterix Corp – Key Facts 8
Quanterix Corp – Major Products and Services 9
Quanterix Corp Pipeline Products by Development Stage 10
Quanterix Corp Pipeline Products Overview 12
AccuPSA Test 12
AccuPSA Test Product Overview 12
Antigen Detection Assay – Tuberculosis 13
Antigen Detection Assay – Tuberculosis Product Overview 13
Blood Test – Concussions/TBI 14
Blood Test – Concussions/TBI Product Overview 14
Diagnostic Blood Test – Huntington’s Disease 15
Diagnostic Blood Test – Huntington’s Disease Product Overview 15
Digital ELISA – Crohn’s Disease 16
Digital ELISA – Crohn’s Disease Product Overview 16
Digital ELISA Assay – C. Difficile 17
Digital ELISA Assay – C. Difficile Product Overview 17
NeuroFilament Light Assay – Alzheimer’s Disease 18
NeuroFilament Light Assay – Alzheimer’s Disease Product Overview 18
POC Device – Neurological Injuries 19
POC Device – Neurological Injuries Product Overview 19
Simoa 3.0 20
Simoa 3.0 Product Overview 20
Simoa 4.0 21
Simoa 4.0 Product Overview 21
Simoa 5.0 22
Simoa 5.0 Product Overview 22
SiMoA HD-1 Analyzer – Botulinum Toxin Assay 23
SiMoA HD-1 Analyzer – Botulinum Toxin Assay Product Overview 23
Simoa HD-1 Analyzer – Lung Cancer 24
Simoa HD-1 Analyzer – Lung Cancer Product Overview 24
Simoa HD-1 Analyzer – Pancreatic Cancer 25
Simoa HD-1 Analyzer – Pancreatic Cancer Product Overview 25
SiMoA HD-1 Analyzer – Prostate Cancer Assay 26
SiMoA HD-1 Analyzer – Prostate Cancer Assay Product Overview 26
Quanterix Corp – Key Competitors 27
Quanterix Corp – Key Employees 28
Quanterix Corp – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Quanterix Corp, Recent Developments 30
May 09, 2018: Quanterix Releases Operating Results for First Quarter 2018 30
Apr 27, 2018: Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone 30
Mar 14, 2018: Quanterix Releases Operating Results for Fourth Quarter and Fiscal Year 2017 31
Mar 08, 2018: New Research Demonstrates Enhanced Sensitivity for Acute HIV Detection Using Quanterix’ Simoa Technology 32
Jan 15, 2018: Quanterix Developing Biomarkers for Concussions 33
Jan 10, 2018: Quanterix: Results of Operations and Financial Condition 34
Nov 10, 2017: Quanterix to Showcase New SR-X Ultra-Sensitive Biomarker Detection System at Neuroscience 2017 34
Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017 35
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 36
Sep 07, 2017: Quanterix To Host Webinar On Predicting The Progression Of Neurodegeneration With A Blood Test 36
Appendix 37
Methodology 37
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Quanterix Corp Pipeline Products and Ongoing Clinical Trials Overview 5
Quanterix Corp Pipeline Products by Equipment Type 6
Quanterix Corp Pipeline Products by Indication 7
Quanterix Corp, Key Facts 8
Quanterix Corp, Major Products and Services 9
Quanterix Corp Number of Pipeline Products by Development Stage 10
Quanterix Corp Pipeline Products Summary by Development Stage 11
AccuPSA Test - Product Status 12
AccuPSA Test - Product Description 12
Antigen Detection Assay - Tuberculosis - Product Status 13
Antigen Detection Assay - Tuberculosis - Product Description 13
Blood Test - Concussions/TBI - Product Status 14
Blood Test - Concussions/TBI - Product Description 14
Diagnostic Blood Test - Huntington’s Disease - Product Status 15
Diagnostic Blood Test - Huntington’s Disease - Product Description 15
Digital ELISA - Crohn’s Disease - Product Status 16
Digital ELISA - Crohn’s Disease - Product Description 16
Digital ELISA Assay - C. Difficile - Product Status 17
Digital ELISA Assay - C. Difficile - Product Description 17
NeuroFilament Light Assay - Alzheimer’s Disease - Product Status 18
NeuroFilament Light Assay - Alzheimer’s Disease - Product Description 18
POC Device - Neurological Injuries - Product Status 19
POC Device - Neurological Injuries - Product Description 19
Simoa 3.0 - Product Status 20
Simoa 3.0 - Product Description 20
Simoa 4.0 - Product Status 21
Simoa 4.0 - Product Description 21
Simoa 5.0 - Product Status 22
Simoa 5.0 - Product Description 22
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Status 23
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Description 23
Simoa HD-1 Analyzer - Lung Cancer - Product Status 24
Simoa HD-1 Analyzer - Lung Cancer - Product Description 24
Simoa HD-1 Analyzer - Pancreatic Cancer - Product Status 25
Simoa HD-1 Analyzer - Pancreatic Cancer - Product Description 25
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status 26
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description 26
Quanterix Corp, Key Employees 28
Quanterix Corp, Subsidiaries 29
Glossary 39

List of Figures
Quanterix Corp Pipeline Products by Equipment Type 6
Quanterix Corp Pipeline Products by Development Stage 10

★海外企業調査レポート[Quanterix Corp (QTRX):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AmerisourceBergen Corp (ABC):医療機器:M&Aディール及び事業提携情報
    Summary AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company. It offers a wide range of services ranging from drug distribution to manufacturer solutions including niche premium logistics services, reimbursement and pharmaceutical consulting servi …
  • Oranje-Nassau Energie BV:石油・ガス:M&Aディール及び事業提携情報
    Summary Oranje-Nassau Energie BV (ONE) is an upstream oil and gas company which focuses on the exploration and production of oil and natural gas. It concentrates on exploration assets in the southern North Sea Ventures such as the Netherlands and the UK. It also has assets in Kowe Block and Agali Bl …
  • Regeneron Pharmaceuticals Inc (REGN):企業の財務・戦略的SWOT分析
    Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Pedernales Electric Cooperative Inc:企業の戦略的SWOT分析
    Pedernales Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Phillips 66 Co (PSX):企業の財務・戦略的SWOT分析
    Phillips 66 Co (PSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Qatar Islamic Bank
    Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report Summary Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Charcot-Marie-Tooth Association:製薬・医療:M&Aディール及び事業提携情報
    Summary Charcot-Marie-Tooth Association (CMTA) is a healthcare service provider that offers healthcare services to patients suffering from charcot marie tooth disease. The association provides services such as public education, patient support, and research promotion. It offers services such as orth …
  • MI Bioresearch Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MI Bioresearch Inc (MI), formerly Molecular Imaging Inc, is a research institute that offers pharmacology research services. The institute offers services such as oncology pharmacology, immuno oncology, in vitro services, imaging and radiation. Its oncology pharmacology include subcutaneous …
  • Societatea Nationala Nuclearelectrica SA (SNN):電力:M&Aディール及び事業提携情報
    Summary Societatea Nationala Nuclearelectrica SA (SNN) is a state owned power generating company. It generates nuclear power and heat using nuclear fission and also manufactures nuclear fuel. SNN is the only company producing electricity based on nuclear technology in Romania. It also produces nucle …
  • Methanol Chemicals Co (2001):企業の財務・戦略的SWOT分析
    Methanol Chemicals Co (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Besso Insurance Group Limited:企業の戦略・SWOT・財務情報
    Besso Insurance Group Limited - Strategy, SWOT and Corporate Finance Report Summary Besso Insurance Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The Kraft Heinz Co:企業の戦略・SWOT・財務情報
    The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report Summary The Kraft Heinz Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • La Francaise Des Jeux SA:企業の戦略的SWOT分析
    La Francaise Des Jeux SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Marico Limited (MARICO):企業の財務・戦略的SWOT分析
    Marico Limited (MARICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • The New York Times Company:企業の戦略・SWOT・財務分析
    The New York Times Company - Strategy, SWOT and Corporate Finance Report Summary The New York Times Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Trammo Inc.:企業の戦略・SWOT・財務情報
    Trammo Inc. - Strategy, SWOT and Corporate Finance Report Summary Trammo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Andeavor Corporation:企業の戦略・SWOT・財務情報
    Andeavor Corporation - Strategy, SWOT and Corporate Finance Report Summary Andeavor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • RSA Insurance Group plc:企業のM&A・事業提携・投資動向
    RSA Insurance Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RSA Insurance Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Hannover Ruck SE:企業の戦略・SWOT・財務分析
    Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report Summary Hannover Ruck SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) manufactures and markets traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, western medicines, dietary supplements, pharmaceutical raw materials an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆